- WBSCR22 confers oxaliplatin resistance in human colorectal cancerYan Dongmei; Tu Linglan; Yuan Haining; Fang Jianfei; Cheng Liyan; Zheng Xiaoliang; Wang XiaojuScientific Reports, 2017, 7: 15443.
- RNA-seq identifies determinants of oxaliplatin sensitivity in colorectal cancer cell linesLi Xin Xiang; Peng Jun Jie; Liang Lei; Huang Li Yong; Li Da Wei; Shi De Bing; Zheng Hong Tu; Cai San JunInternational Journal of Clinical and Experimental Pathology, 2014, 7(7): 3763.
- Pharmacogenomic Analysis Identifies Increased Efficacy of Oxaliplatin in ABCB1 Overexpressing TumorsAnh-Nhan PhamJournal of Pharmacogenomics & Pharmacoproteomics, 2012, 03(04).
期刊论文
Upregulation of CYP2S1 by oxaliplatin is associated with p53 status in colorectal cancer cell lines
12阅读
